Wednesday, February 14, 2018 10:09:42 AM
BIEL Currently Undergoing 400-500% Sales Growth Minimum
which will be reflected in Q2. 1000-2000% Price Gain by August 20th.
Biel: Current Market Cap $18 Million which is PUNY.
Biel is a billion dollar company in the making, having just gained traction in the last few months.
NHS IS HUGE, Government of the U.K. is going to pay for Actipatches.
READ:
FDA Clearance
Back Study Complete, results fantastic and the FDA has requested a pre-submission meeting.
Will clear for all muscular/skeletal indications.
Currently in talks with Walmart and CVS
3-5 calls a day with people wanting to partner or distribute
Average user uses 10.8 Actipatches per year, per the U.K. Study.
Keep in mind People Biel now has
Purdue's Mundi Pharmaceuticals on board in 9 Countries,
Teva's ANDA, INC. selling in America, and
Patterson Medical's Performance Health also selling in America.
Anda has 80 Boots on the Ground and 60,000 customers of which 10,000 are pharmacies.
Performance Health has 120 Boots on the Ground and 40 online sales people calling on
all the Physical Therapy Clinics in America, and most of the Long Term Facilities in America.
NHS decision data says saving of $582.00 per patient when they use Actipatch.
The Future for Biel has Never been brighter!!
https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152432.pdf
NHS is going to pay starting April 4th by Prescription. 100,000 a day see a doctor for pain.
https://globenewswire.com/news-release/2018/01/04/1283220/0/en/BioElectronics-ActiPatch-Drug-Free-Pain-Therapy-Receives-United-Kingdom-National-Health-System-Payment-Coverage.html
Great Interview with their go to guy for sales and marketing.
https://upticknewswire.com/featured-interview-vp-of-sales-keith-nalepka-of-bioelectronics-corp-otcpink-biel/
Study NHS made their decision on. 10.8 Actipatches used a year per patient. Save $582 per patient AFTER
paying for 10.8 Actipatches.
http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf
------------------------
So much Great News will come out in
the next 6 months that I expect "at least" a 1000% increase.
But let's do some pricing to place a PE value on the Company.
$1,000,000 a quarter in Profit is $4,000,000 (Million) a year.
18 Billion shares outstanding and 20 Billion Authorized. I will use the 20 Billion figure.
$4,000,000 divided by 20 Billion = $.0002 X PE =
PE 30 = $.006
PE 60 = $.012
PE 120 =$.024
High growth companies can sport a much higher PE.
Those numbers are for just $1,000,000 profit in a quarter.
How high will Profit be in Q2, Q3 and Q4.
So by the time this company is making profit of $5 million a quarter or $20 Million a year
and it will, the price per share will be at least PE 60 and at least $.06 per share.
Can it achieve that by Q2, Q3, or after Q4 earnings, I do believe so.
Could it do substantially more? Absolutely. Less, perhaps, but this is going to be huge.
RATING: SUPER MONSTER!!
which will be reflected in Q2. 1000-2000% Price Gain by August 20th.
Biel: Current Market Cap $18 Million which is PUNY.
Biel is a billion dollar company in the making, having just gained traction in the last few months.
NHS IS HUGE, Government of the U.K. is going to pay for Actipatches.
READ:
FDA Clearance
Back Study Complete, results fantastic and the FDA has requested a pre-submission meeting.
Will clear for all muscular/skeletal indications.
Currently in talks with Walmart and CVS
3-5 calls a day with people wanting to partner or distribute
Average user uses 10.8 Actipatches per year, per the U.K. Study.
Keep in mind People Biel now has
Purdue's Mundi Pharmaceuticals on board in 9 Countries,
Teva's ANDA, INC. selling in America, and
Patterson Medical's Performance Health also selling in America.
Anda has 80 Boots on the Ground and 60,000 customers of which 10,000 are pharmacies.
Performance Health has 120 Boots on the Ground and 40 online sales people calling on
all the Physical Therapy Clinics in America, and most of the Long Term Facilities in America.
NHS decision data says saving of $582.00 per patient when they use Actipatch.
The Future for Biel has Never been brighter!!
https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152432.pdf
NHS is going to pay starting April 4th by Prescription. 100,000 a day see a doctor for pain.
https://globenewswire.com/news-release/2018/01/04/1283220/0/en/BioElectronics-ActiPatch-Drug-Free-Pain-Therapy-Receives-United-Kingdom-National-Health-System-Payment-Coverage.html
Great Interview with their go to guy for sales and marketing.
https://upticknewswire.com/featured-interview-vp-of-sales-keith-nalepka-of-bioelectronics-corp-otcpink-biel/
Study NHS made their decision on. 10.8 Actipatches used a year per patient. Save $582 per patient AFTER
paying for 10.8 Actipatches.
http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf
------------------------
So much Great News will come out in
the next 6 months that I expect "at least" a 1000% increase.
But let's do some pricing to place a PE value on the Company.
$1,000,000 a quarter in Profit is $4,000,000 (Million) a year.
18 Billion shares outstanding and 20 Billion Authorized. I will use the 20 Billion figure.
$4,000,000 divided by 20 Billion = $.0002 X PE =
PE 30 = $.006
PE 60 = $.012
PE 120 =$.024
High growth companies can sport a much higher PE.
Those numbers are for just $1,000,000 profit in a quarter.
How high will Profit be in Q2, Q3 and Q4.
So by the time this company is making profit of $5 million a quarter or $20 Million a year
and it will, the price per share will be at least PE 60 and at least $.06 per share.
Can it achieve that by Q2, Q3, or after Q4 earnings, I do believe so.
Could it do substantially more? Absolutely. Less, perhaps, but this is going to be huge.
RATING: SUPER MONSTER!!
